Philip Morris to Produce in Egypt with Eastern Co.

Sep.02.2022
Philip Morris to Produce in Egypt with Eastern Co.
Philip Morris will produce cigarettes in Egypt through its subsidiary Eastern Co, following a partnership deal with UTC.

Source: akolosov.art


According to a report by Egypt Daily News, Philip Morris International will begin producing products for the Egyptian market through its subsidiary, Orient Company, which is part of its joint venture tobacco company, United Tobacco Company (UTC).


Currently, the licensed entity Oriental Company will continue producing Philip Morris' cigarette products until their production inventory is depleted.


Philip Morris expressed pride in its strategic partnership with the state-owned tobacco company that has lasted almost half a century and looks forward to maintaining this partnership through Eastern Co.'s holdings in UTC. According to Enterprise Press, in May, the Egyptian Parliament approved Eastern Co.'s plan to purchase a 25% stake in UTC for 100 million Egyptian pounds ($5.2 million).


The Chairman and CEO of Eastern Co., Hani Aman, announced that his company will be represented by two members of the UTC board of directors.


The acquisition is part of a deal between a Philip Morris subsidiary and an East Asian company to produce cigarettes locally. UTC was the only company to bid last year after other companies complained that the bidding terms would establish a monopoly in the local market.


Philip Morris has confirmed its commitment to all existing contractual agreements with traders and suppliers to ensure the supply of its products across all provinces in Egypt. The company has stated that it will continue to offer all its products at the same price as recently set by official authorities and will not be changing packaging.


Oman has stated that Eastern Company is currently attempting to absorb the increased production costs resulting from recent rises in raw material expenses internally.


He pointed out that apart from the impact of rising US dollar prices on other products, supply chain disruptions also directly affect the rise of some production inputs.


The tobacco business report of Dongfang Company stated that its revenue for the first nine months of the 2021-2022 fiscal year was EGP 12.78 billion, which is a 5% increase from the same period last year.


Statement:


This article is compiled from third-party information and is intended for industry-related exchange and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the translation process, the translated article may not fully reflect the original expression. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign-related expressions and positions.


The compilation of information in this article are the property of the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
HM Revenue and Customs announced that from April 1, 2026, UK vaping product manufacturers, importers and warehousekeepers can apply for approval under Vaping Products Duty (VPD) and the Vaping Duty Stamps Scheme (VDS). Under new GOV.UK guidance, Vaping Products Duty will take effect on October 1, 2026 and will apply to all vaping liquids, whether they contain nicotine or not.
Apr.02 by 2FIRSTS.ai
Dutch Data Show 244 Companies Continued Illegal Vape Sales After Two Fines
Dutch Data Show 244 Companies Continued Illegal Vape Sales After Two Fines
According to RTL Nieuws, citing figures from the Netherlands Food and Consumer Product Safety Authority (NVWA), hundreds of Dutch shops continue to sell illegal vapes, often even after repeated fines.
Apr.08 by 2FIRSTS.ai
Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Jay Jones is backing new vape enforcement legislation that he said would do more than warn people about the dangers of vaping. The proposal would tighten rules on which products can be sold and increase enforcement aimed at keeping vapes out of the hands of young people.
Mar.24 by 2FIRSTS.ai
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12